Enhanced S-Cone Syndrome

Mendelian MONDO:0100288 Pathograph 7 Show in embeddings browser Ophthalmological Disease Retinal Dystrophy Inherited retinal dystrophy

Enhanced S-cone syndrome (ESCS) is a rare autosomal recessive inherited retinal dystrophy caused by biallelic loss-of-function variants in NR2E3 (photoreceptor-specific nuclear receptor, PNR), a photoreceptor-restricted ligand-dependent nuclear-hormone-receptor transcription factor. Uniquely among inherited retinal diseases, ESCS manifests a paradoxical gain of function of a photoreceptor subtype: loss of NR2E3-mediated repression of the S (short-wavelength, blue) cone genetic program during retinogenesis mis-specifies photoreceptor cell fate, so that cells that would normally become rods instead adopt an S-cone identity. The result is an excess of S cones at the expense of rods and L/M (red/green) cones, producing supranormal S-cone sensitivity, rudimentary or absent rod function with lifelong night blindness, reduced L/M-cone (color) vision, and a characteristic electroretinogram. The dysplastic, rod-deficient retina is also progressively degenerative, frequently complicated by cystoid maculopathy and intraretinal schisis; the most severe end of the NR2E3 phenotypic spectrum is historically termed Goldmann-Favre syndrome. ESCS is distinct from the rare dominant p.Gly56Arg NR2E3 allele that causes autosomal dominant retinitis pigmentosa.

Ask OpenScientist

Ask a research question about Enhanced S-Cone Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
4
Pathophys.
7
Phenotypes
7
Pathograph
1
Genes
3
Medical Actions
1
Trials
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
ESCS is inherited in an autosomal recessive manner; affected individuals carry biallelic (homozygous or compound heterozygous) pathogenic NR2E3 variants. A single dominant p.Gly56Arg NR2E3 allele instead causes autosomal dominant retinitis pigmentosa and is not part of the ESCS phenotype.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:10655056 SUPPORT Human Clinical
"ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light"
The gene-discovery study explicitly classifies ESCS as an autosomal recessive retinopathy.
clinicaltrials:NCT02338973 SUPPORT Human Clinical
"Those with ESCS must have two mutations in the NR2E3 gene."
The clinical trial eligibility criteria require biallelic NR2E3 mutations, confirming the recessive, two-hit genetic basis of ESCS.
⚙

Pathophysiology

4
NR2E3 Loss of Function
The initiating lesion is biallelic loss of function of NR2E3, which encodes a photoreceptor-specific ligand-dependent nuclear-receptor transcription factor whose expression is restricted to the outer nuclear layer of the retina. NR2E3 normally acts within maturing rod precursors to activate rod genes and to repress the cone (particularly the S-cone) transcriptional program. Pathogenic variants cluster in the conserved DNA-binding and ligand-binding domains; the novel homozygous c.1182del p.(Ile395*) allele deletes the entire NR2E3 AF2 activation domain, abolishing coregulator-dependent transcriptional activity.
photoreceptor cell CL:0000210 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves photoreceptor cell (CL:0000210). CL:0000210 is a cell type from the Cell Ontology.
NR2E3 hgnc:7974 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves decreased NR2E3 (hgnc:7974). hgnc:7974 is a gene from the HUGO Gene Nomenclature Committee. ↓ DECREASED
regulation of DNA-templated transcription GO:0006355 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased regulation of DNA-templated transcription (GO:0006355). GO:0006355 is a biological process from the Gene Ontology. ↓ DECREASED eye photoreceptor cell development GO:0042462 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal eye photoreceptor cell development (GO:0042462). GO:0042462 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Photoreceptor Cell-Fate Mis-specification and S-Cone Excess Loss of NR2E3 transcriptional activity removes the repression of the S-cone program in rod-committed precursors, redirecting photoreceptor cell fate.
Show evidence (3 references)
PMID:10655056 SUPPORT Human Clinical
"In 94% of a cohort of ESCS probands we found mutations in NR2E3 (also known as PNR), which encodes a retinal nuclear receptor recently discovered to be a ligand-dependent transcription factor."
Establishes NR2E3 as the causative gene in the large majority of ESCS probands and defines it as a retinal ligand-dependent transcription factor.
PMID:19718767 SUPPORT Human Clinical
"its physiological activity is essential for proper rod and cone photoreceptor development and maintenance"
Confirms NR2E3 as a photoreceptor-restricted transcription factor essential for photoreceptor development and maintenance.
PMID:42427056 SUPPORT Human Clinical
"resulting in the complete deletion of the NR2E3 AF2 domain which is associated with the observed phenotype consistent with retinal degeneration pathway described in Enhanced S-Cone Syndrome (ESCS)"
Documents a novel homozygous deletion abolishing the NR2E3 AF2 activation domain as a loss-of-function cause of the ESCS phenotype.
Photoreceptor Cell-Fate Mis-specification and S-Cone Excess
In the absence of NR2E3 repression, the retina overproduces S (blue) cones at the expense of rods and L/M cones. This developmental cell-fate mis-specification is the mechanistic signature that distinguishes ESCS from the rod-first apoptotic pathway of typical retinitis pigmentosa: rather than a mature photoreceptor topography being depleted, the retina is built with an abnormal S-to-L/M cone ratio and a near-absence of rods, and is disorganized from the outset.
S cone cell CL:0003050 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves increased S cone cell (CL:0003050). CL:0003050 is a cell type from the Cell Ontology. ↑ INCREASED retinal rod cell CL:0000604 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves decreased retinal rod cell (CL:0000604). CL:0000604 is a cell type from the Cell Ontology. ↓ DECREASED retinal cone cell CL:0000573 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal cone cell (CL:0000573). CL:0000573 is a cell type from the Cell Ontology.
retinal rod cell differentiation GO:0060221 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased retinal rod cell differentiation (GO:0060221). GO:0060221 is a biological process from the Gene Ontology. ↓ DECREASED retinal cone cell differentiation GO:0042670 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal retinal cone cell differentiation (GO:0042670). GO:0042670 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Rod Photoreceptor Deficiency and Scotopic Dysfunction Redirection of rod precursors toward an S-cone fate leaves the retina with rudimentary or absent rod photoreceptors.
Progressive Retinal Degeneration and Maculopathy The dysplastic, disorganized photoreceptor mosaic is intrinsically unstable and undergoes progressive degeneration over time.
Show evidence (3 references)
PMID:11773633 SUPPORT Human Clinical
"may result from abnormal cell-fate determination, leading to excess S cones at the expense of other photoreceptor subtypes"
Directly states the cell-fate-mis-specification mechanism producing excess S cones at the expense of rods and L/M cones.
PMID:11773633 SUPPORT Human Clinical
"No rods were identified, but cones were increased approximately 2-fold, and 92% were S cones."
Postmortem quantification of an ESCS retina confirms rod absence and marked S-cone predominance.
PMID:10655056 SUPPORT Human Clinical
"The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development."
Attributes the abnormal S-to-L/M cone ratio to disordered photoreceptor cell-fate determination during retinal development.
Rod Photoreceptor Deficiency and Scotopic Dysfunction
Because rod precursors are diverted to an S-cone fate, the ESCS retina has rudimentary or absent rod photoreceptors and correspondingly absent scotopic (rod-mediated) function. Clinically this produces lifelong night blindness, typically the earliest symptom, and a non-detectable dark-adapted rod electroretinogram.
retinal rod cell CL:0000604 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves decreased retinal rod cell (CL:0000604). CL:0000604 is a cell type from the Cell Ontology. ↓ DECREASED
visual perception GO:0007601 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased visual perception (GO:0007601). GO:0007601 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Night blindness Rod deficiency abolishes scotopic vision, producing nyctalopia from early life.
Show evidence (1 reference)
PMID:19718767 SUPPORT Human Clinical
"The clinical phenotype common to all these patients is night blindness, rudimental or absent rod function, and hyperfunction of the "blue" S-cones."
Defines the shared NR2E3 phenotype of night blindness with rudimentary or absent rod function and S-cone hyperfunction.
Progressive Retinal Degeneration and Maculopathy
Beyond the developmental defect, the ESCS retina undergoes progressive degeneration, retaining photoreceptors only in central and far-peripheral regions over time. Cystoid macular edema and intraretinal schisis cysts are frequent complications (the Goldmann-Favre end of the spectrum), causing additional loss of central vision.
photoreceptor cell CL:0000210 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves decreased photoreceptor cell (CL:0000210). CL:0000210 is a cell type from the Cell Ontology. ↓ DECREASED
visual perception GO:0007601 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased visual perception (GO:0007601). GO:0007601 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:11773633 SUPPORT Human Clinical
"The retina was also degenerate, retaining photoreceptors in only the central and far peripheral regions."
Documents the progressive degenerative loss of photoreceptors in the ESCS retina.
clinicaltrials:NCT02338973 SUPPORT Human Clinical
"People with rod-cone dystrophy (RCD) or enhanced S-cone syndrome (ESCS) have excess fluid under the retina of their eye."
Confirms the intraretinal fluid accumulation (macular edema / schisis) that complicates ESCS and threatens central vision.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Enhanced S-Cone Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

7
Eye 4
Night blindness VERY_FREQUENT Nyctalopia HP:0000662 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Night blindness, annotated with Nyctalopia (HP:0000662). HP:0000662 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10655056 SUPPORT Human Clinical
"People with ESCS also suffer visual loss, with night blindness occurring from early in life"
Directly reports early-onset night blindness as a cardinal ESCS phenotype.
Abnormal electroretinogram HP:0000512 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal electroretinogram (HP:0000512). HP:0000512 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11773633 SUPPORT Human Clinical
"we documented an abnormal ratio of S to L/M cone function and progressive retinal degeneration"
The abnormal S-to-L/M cone functional ratio is the electrophysiologic hallmark of ESCS.
Reduced visual acuity HP:0007663 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reduced visual acuity (HP:0007663). HP:0007663 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10655056 SUPPORT Human Clinical
"People with ESCS also suffer visual loss"
Reports visual loss as part of the ESCS phenotype.
Color vision defect HP:0000551 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Color vision defect (HP:0000551). HP:0000551 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10655056 SUPPORT Human Clinical
"varying degrees of L (long, red)- and M (middle, green)-cone vision"
Documents variably reduced L- and M-cone (color) vision in ESCS.
Other 3
Retinal degeneration VERY_FREQUENT HP:0000546 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Retinal degeneration (HP:0000546). HP:0000546 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10655056 SUPPORT Human Clinical
"varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration"
Lists retinal degeneration among the core ESCS clinical features.
Cystoid macular edema HP:0011505 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cystoid macular edema (HP:0011505). HP:0011505 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40184577 SUPPORT Human Clinical
"macular cystoid spaces were most apparent in the INL of XLRS subjects and in the OPL+ONL of ESCS subjects"
OCT of ESCS patients localizes macular cystoid spaces to the OPL+ONL, documenting cystoid maculopathy as a characteristic ESCS complication.
Retinoschisis HP:0030502 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Retinoschisis (HP:0030502). HP:0030502 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40184577 SUPPORT Human Clinical
"all 7 ESCS subjects had macular schisis by OCT"
All ESCS subjects in this OCT study had macular schisis, directly documenting retinoschisis as a characteristic feature of the disease and of the more severe (Goldmann-Favre) end of the NR2E3 spectrum.
🧬

Genetic Associations

1
NR2E3 pathogenic variants (Causative)
Gene: NR2E3 hgnc:7974 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is NR2E3 (hgnc:7974). hgnc:7974 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal recessive
Show evidence (3 references)
PMID:11773633 SUPPORT Human Clinical
"In 16 ESCS patients with the most common NR2E3 mutation, R311Q, we documented an abnormal ratio of S to L/M cone function"
Identifies R311Q as the most common NR2E3 mutation in ESCS.
PMID:19718767 SUPPORT Human Clinical
"A high proportion of mutations are located in the evolutionarily-conserved DNA-binding domains (DBDs) and ligand-binding domains (LBDs) of NR2E3."
Localizes the majority of pathogenic NR2E3 variants to the conserved DBD and LBD.
PMID:42427056 SUPPORT Human Clinical
"Genetic analysis identified a novel homozygous deletion in NR2E3 gene: Chr15(GRCh37): g.71817633del c.1182del p. (Ile395*) resulting in the complete deletion of the NR2E3 AF2 domain"
Reports a novel homozygous AF2-domain-deleting NR2E3 variant causing ESCS.
💊

Medical Actions

3
Carbonic Anhydrase Inhibitor for Cystoid Macular Edema
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: carbonic anhydrase inhibitor NCIT:C29577 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses carbonic anhydrase inhibitor (NCIT:C29577). NCIT:C29577 is a therapeutic agent from the NCI Thesaurus. acetazolamide CHEBI:27690 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses acetazolamide (CHEBI:27690). CHEBI:27690 is a therapeutic agent from Chemical Entities of Biological Interest.
Topical or systemic carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide) are used to reduce the cystoid macular edema and intraretinal schisis that complicate ESCS, aiming to preserve central vision. There is no treatment that reverses the underlying photoreceptor cell-fate defect.
Topical Interferon Gamma-1b (Investigational)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: interferon gamma-1b NCIT:C100089 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses interferon gamma-1b (NCIT:C100089). NCIT:C100089 is a therapeutic agent from the NCI Thesaurus.
Topical interferon gamma-1b eyedrops have been evaluated in an early-phase (Phase I/II) trial to reduce macular edema and intraretinal schisis cysts in ESCS and rod-cone dystrophy.
Show evidence (1 reference)
clinicaltrials:NCT02338973 SUPPORT Human Clinical
"The medicine interferon gamma-1b may help people with these diseases."
The trial evaluates topical interferon gamma-1b for the macular edema/schisis of ESCS.
Supportive and Low-Vision Care
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Management is largely supportive: low-vision aids and rehabilitation, monitoring for maculopathy, and genetic counseling for this autosomal recessive disorder.
📊

Prevalence

1
Worldwide
Point Prevalence Ultra Rare
ESCS is an ultra-rare inherited retinal dystrophy. Only a few hundred cases and 32 distinct NR2E3 mutations had been reported by 2009; precise population prevalence is not documented.
Show evidence (1 reference)
PMID:19718767 SUPPORT Human Clinical
"Thirty-two different mutations in NR2E3 have been identified in either homozygous or compound heterozygous state"
The limited catalogue of reported NR2E3 mutations reflects the ultra-rare nature of NR2E3-linked retinal degenerations including ESCS.
🔬

Clinical Trials

1
NCT02338973 PHASE_I UNKNOWN
Pilot Phase I/II study of topically administered interferon gamma-1b for macular edema and intraretinal schisis cysts in rod-cone dystrophy and enhanced S-cone syndrome, requiring biallelic NR2E3 mutations for ESCS enrollment.
Target Phenotypes: Cystoid macular edema HP:0011505 Human Phenotype Ontology (HP) Relation: this clinical trial targets this phenotype This clinical trial targets Cystoid macular edema (HP:0011505). HP:0011505 is a phenotype from the Human Phenotype Ontology. Retinoschisis HP:0030502 Human Phenotype Ontology (HP) Relation: this clinical trial targets this phenotype This clinical trial targets Retinoschisis (HP:0030502). HP:0030502 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
clinicaltrials:NCT02338973 SUPPORT Human Clinical
"To see if the medicine can decrease retina fluid and help prevent vision loss."
The trial's objective is to reduce intraretinal fluid and prevent vision loss in ESCS and rod-cone dystrophy.
{ }

Source YAML

click to show 
name: Enhanced S-Cone Syndrome
creation_date: "2026-07-10T00:00:00Z"
category: Mendelian
description: >
  Enhanced S-cone syndrome (ESCS) is a rare autosomal recessive inherited retinal
  dystrophy caused by biallelic loss-of-function variants in NR2E3
  (photoreceptor-specific nuclear receptor, PNR), a photoreceptor-restricted
  ligand-dependent nuclear-hormone-receptor transcription factor. Uniquely among
  inherited retinal diseases, ESCS manifests a paradoxical gain of function of a
  photoreceptor subtype: loss of NR2E3-mediated repression of the S
  (short-wavelength, blue) cone genetic program during retinogenesis mis-specifies
  photoreceptor cell fate, so that cells that would normally become rods instead
  adopt an S-cone identity. The result is an excess of S cones at the expense of
  rods and L/M (red/green) cones, producing supranormal S-cone sensitivity,
  rudimentary or absent rod function with lifelong night blindness, reduced
  L/M-cone (color) vision, and a characteristic electroretinogram. The dysplastic,
  rod-deficient retina is also progressively degenerative, frequently complicated
  by cystoid maculopathy and intraretinal schisis; the most severe end of the
  NR2E3 phenotypic spectrum is historically termed Goldmann-Favre syndrome. ESCS
  is distinct from the rare dominant p.Gly56Arg NR2E3 allele that causes autosomal
  dominant retinitis pigmentosa.
disease_term:
  preferred_term: enhanced S-cone syndrome
  term:
    id: MONDO:0100288
    label: enhanced S-cone syndrome
synonyms:
- ESCS
- enhanced S cone syndrome
- NR2E3-related retinopathy
- Goldmann-Favre syndrome
parents:
- Ophthalmological Disease
- Retinal Dystrophy
- Inherited retinal dystrophy
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >
    ESCS is inherited in an autosomal recessive manner; affected individuals carry
    biallelic (homozygous or compound heterozygous) pathogenic NR2E3 variants. A
    single dominant p.Gly56Arg NR2E3 allele instead causes autosomal dominant
    retinitis pigmentosa and is not part of the ESCS phenotype.
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light"
    explanation: >
      The gene-discovery study explicitly classifies ESCS as an autosomal
      recessive retinopathy.
  - reference: clinicaltrials:NCT02338973
    reference_title: "Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Those with ESCS must have two mutations in the NR2E3 gene."
    explanation: >
      The clinical trial eligibility criteria require biallelic NR2E3 mutations,
      confirming the recessive, two-hit genetic basis of ESCS.
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: ULTRA_RARE
  notes: >
    ESCS is an ultra-rare inherited retinal dystrophy. Only a few hundred cases
    and 32 distinct NR2E3 mutations had been reported by 2009; precise
    population prevalence is not documented.
  evidence:
  - reference: PMID:19718767
    reference_title: "NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thirty-two different mutations in NR2E3 have been identified in either homozygous or compound heterozygous state"
    explanation: >
      The limited catalogue of reported NR2E3 mutations reflects the ultra-rare
      nature of NR2E3-linked retinal degenerations including ESCS.
pathophysiology:
- name: NR2E3 Loss of Function
  conforms_to: "photoreceptor_degeneration#Photoreceptor Gene Defect"
  description: >
    The initiating lesion is biallelic loss of function of NR2E3, which encodes a
    photoreceptor-specific ligand-dependent nuclear-receptor transcription factor
    whose expression is restricted to the outer nuclear layer of the retina.
    NR2E3 normally acts within maturing rod precursors to activate rod genes and
    to repress the cone (particularly the S-cone) transcriptional program.
    Pathogenic variants cluster in the conserved DNA-binding and ligand-binding
    domains; the novel homozygous c.1182del p.(Ile395*) allele deletes the entire
    NR2E3 AF2 activation domain, abolishing coregulator-dependent transcriptional
    activity.
  role: trigger
  gene:
    preferred_term: NR2E3
    modifier: DECREASED
    term:
      id: hgnc:7974
      label: NR2E3
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  biological_processes:
  - preferred_term: regulation of DNA-templated transcription
    modifier: DECREASED
    term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
  - preferred_term: eye photoreceptor cell development
    modifier: ABNORMAL
    term:
      id: GO:0042462
      label: eye photoreceptor cell development
  downstream:
  - target: Photoreceptor Cell-Fate Mis-specification and S-Cone Excess
    description: >
      Loss of NR2E3 transcriptional activity removes the repression of the S-cone
      program in rod-committed precursors, redirecting photoreceptor cell fate.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In 94% of a cohort of ESCS probands we found mutations in NR2E3 (also known as PNR), which encodes a retinal nuclear receptor recently discovered to be a ligand-dependent transcription factor."
    explanation: >
      Establishes NR2E3 as the causative gene in the large majority of ESCS
      probands and defines it as a retinal ligand-dependent transcription factor.
  - reference: PMID:19718767
    reference_title: "NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "its physiological activity is essential for proper rod and cone photoreceptor development and maintenance"
    explanation: >
      Confirms NR2E3 as a photoreceptor-restricted transcription factor essential
      for photoreceptor development and maintenance.
  - reference: PMID:42427056
    reference_title: "Autosomal recessive retinopathy (ARRP) associated with a novel variant in NR2E3 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "resulting in the complete deletion of the NR2E3 AF2 domain which is associated with the observed phenotype consistent with retinal degeneration pathway described in Enhanced S-Cone Syndrome (ESCS)"
    explanation: >
      Documents a novel homozygous deletion abolishing the NR2E3 AF2 activation
      domain as a loss-of-function cause of the ESCS phenotype.
- name: Photoreceptor Cell-Fate Mis-specification and S-Cone Excess
  description: >
    In the absence of NR2E3 repression, the retina overproduces S (blue) cones at
    the expense of rods and L/M cones. This developmental cell-fate
    mis-specification is the mechanistic signature that distinguishes ESCS from the
    rod-first apoptotic pathway of typical retinitis pigmentosa: rather than a
    mature photoreceptor topography being depleted, the retina is built with an
    abnormal S-to-L/M cone ratio and a near-absence of rods, and is disorganized
    from the outset.
  role: central_effector
  cell_types:
  - preferred_term: S cone cell
    modifier: INCREASED
    term:
      id: CL:0003050
      label: S cone cell
  - preferred_term: retinal rod cell
    modifier: DECREASED
    term:
      id: CL:0000604
      label: retinal rod cell
  - preferred_term: retinal cone cell
    term:
      id: CL:0000573
      label: retinal cone cell
  biological_processes:
  - preferred_term: retinal rod cell differentiation
    modifier: DECREASED
    term:
      id: GO:0060221
      label: retinal rod cell differentiation
  - preferred_term: retinal cone cell differentiation
    modifier: ABNORMAL
    term:
      id: GO:0042670
      label: retinal cone cell differentiation
  downstream:
  - target: Rod Photoreceptor Deficiency and Scotopic Dysfunction
    description: >
      Redirection of rod precursors toward an S-cone fate leaves the retina with
      rudimentary or absent rod photoreceptors.
    causal_link_type: DIRECT
  - target: Progressive Retinal Degeneration and Maculopathy
    description: >
      The dysplastic, disorganized photoreceptor mosaic is intrinsically unstable
      and undergoes progressive degeneration over time.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:11773633
    reference_title: "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "may result from abnormal cell-fate determination, leading to excess S cones at the expense of other photoreceptor subtypes"
    explanation: >
      Directly states the cell-fate-mis-specification mechanism producing excess
      S cones at the expense of rods and L/M cones.
  - reference: PMID:11773633
    reference_title: "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "No rods were identified, but cones were increased approximately 2-fold, and 92% were S cones."
    explanation: >
      Postmortem quantification of an ESCS retina confirms rod absence and marked
      S-cone predominance.
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development."
    explanation: >
      Attributes the abnormal S-to-L/M cone ratio to disordered photoreceptor
      cell-fate determination during retinal development.
- name: Rod Photoreceptor Deficiency and Scotopic Dysfunction
  description: >
    Because rod precursors are diverted to an S-cone fate, the ESCS retina has
    rudimentary or absent rod photoreceptors and correspondingly absent scotopic
    (rod-mediated) function. Clinically this produces lifelong night blindness,
    typically the earliest symptom, and a non-detectable dark-adapted rod
    electroretinogram.
  role: effector
  cell_types:
  - preferred_term: retinal rod cell
    modifier: DECREASED
    term:
      id: CL:0000604
      label: retinal rod cell
  biological_processes:
  - preferred_term: visual perception
    modifier: DECREASED
    term:
      id: GO:0007601
      label: visual perception
  downstream:
  - target: Night blindness
    description: >
      Rod deficiency abolishes scotopic vision, producing nyctalopia from early
      life.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:19718767
    reference_title: "NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical phenotype common to all these patients is night blindness, rudimental or absent rod function, and hyperfunction of the \"blue\" S-cones."
    explanation: >
      Defines the shared NR2E3 phenotype of night blindness with rudimentary or
      absent rod function and S-cone hyperfunction.
- name: Progressive Retinal Degeneration and Maculopathy
  conforms_to: "photoreceptor_degeneration#Progressive Visual Field Loss and Blindness"
  description: >
    Beyond the developmental defect, the ESCS retina undergoes progressive
    degeneration, retaining photoreceptors only in central and far-peripheral
    regions over time. Cystoid macular edema and intraretinal schisis cysts are
    frequent complications (the Goldmann-Favre end of the spectrum), causing
    additional loss of central vision.
  role: consequence
  cell_types:
  - preferred_term: photoreceptor cell
    modifier: DECREASED
    term:
      id: CL:0000210
      label: photoreceptor cell
  biological_processes:
  - preferred_term: visual perception
    modifier: DECREASED
    term:
      id: GO:0007601
      label: visual perception
  evidence:
  - reference: PMID:11773633
    reference_title: "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The retina was also degenerate, retaining photoreceptors in only the central and far peripheral regions."
    explanation: >
      Documents the progressive degenerative loss of photoreceptors in the ESCS
      retina.
  - reference: clinicaltrials:NCT02338973
    reference_title: "Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "People with rod-cone dystrophy (RCD) or enhanced S-cone syndrome (ESCS) have excess fluid under the retina of their eye."
    explanation: >
      Confirms the intraretinal fluid accumulation (macular edema / schisis)
      that complicates ESCS and threatens central vision.
phenotypes:
- category: Ophthalmic
  name: Night blindness
  frequency: VERY_FREQUENT
  description: >
    Rudimentary or absent rod function produces nyctalopia from early in life,
    typically the earliest presenting symptom of ESCS.
  phenotype_term:
    preferred_term: Night blindness
    term:
      id: HP:0000662
      label: Nyctalopia
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "People with ESCS also suffer visual loss, with night blindness occurring from early in life"
    explanation: >
      Directly reports early-onset night blindness as a cardinal ESCS phenotype.
- category: Ophthalmic
  name: Abnormal electroretinogram
  description: >
    The ESCS electroretinogram is pathognomonic: rod-mediated responses are
    non-detectable while the S-cone system is supranormal, and the S-to-L/M cone
    functional ratio is abnormal.
  phenotype_term:
    preferred_term: Abnormal electroretinogram
    term:
      id: HP:0000512
      label: Abnormal electroretinogram
  reports_on:
  - target: Photoreceptor Cell-Fate Mis-specification and S-Cone Excess
    relationship: READOUT_OF
    endpoint_context: DIAGNOSTIC
    interpretation: ERG rod and S-cone responses as the electrophysiological readout of the abnormal photoreceptor mosaic (rod deficiency with S-cone excess)
  evidence:
  - reference: PMID:11773633
    reference_title: "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we documented an abnormal ratio of S to L/M cone function and progressive retinal degeneration"
    explanation: >
      The abnormal S-to-L/M cone functional ratio is the electrophysiologic
      hallmark of ESCS.
- category: Ophthalmic
  name: Reduced visual acuity
  description: >
    Patients suffer visual loss from the combined effects of abnormal
    photoreceptor development, progressive retinal degeneration, and maculopathy.
  phenotype_term:
    preferred_term: Reduced visual acuity
    term:
      id: HP:0007663
      label: Reduced visual acuity
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "People with ESCS also suffer visual loss"
    explanation: >
      Reports visual loss as part of the ESCS phenotype.
- category: Ophthalmic
  name: Color vision defect
  description: >
    Reduced L (red)- and M (green)-cone function impairs color vision, reflecting
    the depletion of L/M cones relative to the overproduced S cones.
  phenotype_term:
    preferred_term: Color vision defect
    term:
      id: HP:0000551
      label: Color vision defect
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "varying degrees of L (long, red)- and M (middle, green)-cone vision"
    explanation: >
      Documents variably reduced L- and M-cone (color) vision in ESCS.
- category: Ophthalmic
  name: Retinal degeneration
  frequency: VERY_FREQUENT
  description: >
    ESCS retinas are progressively degenerative in addition to being
    developmentally abnormal.
  phenotype_term:
    preferred_term: Retinal degeneration
    term:
      id: HP:0000546
      label: Retinal degeneration
  evidence:
  - reference: PMID:10655056
    reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration"
    explanation: >
      Lists retinal degeneration among the core ESCS clinical features.
- category: Ophthalmic
  name: Cystoid macular edema
  description: >
    Intraretinal fluid accumulation and cystoid maculopathy are frequent
    complications of ESCS that further reduce central vision.
  phenotype_term:
    preferred_term: Cystoid macular edema
    term:
      id: HP:0011505
      label: Cystoid macular edema
  evidence:
  - reference: PMID:40184577
    reference_title: "Comparison of retinal structure and schisis location in X-linked retinoschisis and enhanced S-cone syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "macular cystoid spaces were most apparent in the INL of XLRS subjects and in the OPL+ONL of ESCS subjects"
    explanation: >
      OCT of ESCS patients localizes macular cystoid spaces to the OPL+ONL,
      documenting cystoid maculopathy as a characteristic ESCS complication.
- category: Ophthalmic
  name: Retinoschisis
  description: >
    Intraretinal schisis cysts, most prominent at the macula, are characteristic
    of the more severe (Goldmann-Favre) end of the NR2E3/ESCS spectrum and
    manifest as the intraretinal fluid targeted by ESCS therapy trials.
  phenotype_term:
    preferred_term: Retinoschisis
    term:
      id: HP:0030502
      label: Retinoschisis
  evidence:
  - reference: PMID:40184577
    reference_title: "Comparison of retinal structure and schisis location in X-linked retinoschisis and enhanced S-cone syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "all 7 ESCS subjects had macular schisis by OCT"
    explanation: >
      All ESCS subjects in this OCT study had macular schisis, directly
      documenting retinoschisis as a characteristic feature of the disease and
      of the more severe (Goldmann-Favre) end of the NR2E3 spectrum.
genetic:
- name: NR2E3 pathogenic variants
  gene_term:
    preferred_term: NR2E3
    term:
      id: hgnc:7974
      label: NR2E3
  association: Causative
  relationship_type: CAUSATIVE
  notes: >
    ESCS is caused by biallelic NR2E3 variants. The recurrent p.Arg311Gln (R311Q)
    ligand-binding-domain substitution is the most common ESCS allele; pathogenic
    variants concentrate in the conserved DNA-binding and ligand-binding domains.
    A novel homozygous c.1182del p.(Ile395*) deleting the AF2 activation domain
    has also been reported. The single dominant p.Gly56Arg allele causes autosomal
    dominant retinitis pigmentosa rather than ESCS.
  inheritance:
  - name: Autosomal recessive
    evidence:
    - reference: PMID:10655056
      reference_title: "Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light"
      explanation: >
        The gene-discovery study classifies ESCS as autosomal recessive.
  evidence:
  - reference: PMID:11773633
    reference_title: "The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In 16 ESCS patients with the most common NR2E3 mutation, R311Q, we documented an abnormal ratio of S to L/M cone function"
    explanation: >
      Identifies R311Q as the most common NR2E3 mutation in ESCS.
  - reference: PMID:19718767
    reference_title: "NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A high proportion of mutations are located in the evolutionarily-conserved DNA-binding domains (DBDs) and ligand-binding domains (LBDs) of NR2E3."
    explanation: >
      Localizes the majority of pathogenic NR2E3 variants to the conserved DBD
      and LBD.
  - reference: PMID:42427056
    reference_title: "Autosomal recessive retinopathy (ARRP) associated with a novel variant in NR2E3 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genetic analysis identified a novel homozygous deletion in NR2E3 gene: Chr15(GRCh37): g.71817633del c.1182del p. (Ile395*) resulting in the complete deletion of the NR2E3 AF2 domain"
    explanation: >
      Reports a novel homozygous AF2-domain-deleting NR2E3 variant causing ESCS.
treatments:
- name: Carbonic Anhydrase Inhibitor for Cystoid Macular Edema
  description: >
    Topical or systemic carbonic anhydrase inhibitors (e.g., acetazolamide,
    dorzolamide) are used to reduce the cystoid macular edema and intraretinal
    schisis that complicate ESCS, aiming to preserve central vision. There is no
    treatment that reverses the underlying photoreceptor cell-fate defect.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: carbonic anhydrase inhibitor
      term:
        id: NCIT:C29577
        label: Carbonic Anhydrase Inhibitor
    - preferred_term: acetazolamide
      term:
        id: CHEBI:27690
        label: acetazolamide
- name: Topical Interferon Gamma-1b (Investigational)
  description: >
    Topical interferon gamma-1b eyedrops have been evaluated in an early-phase
    (Phase I/II) trial to reduce macular edema and intraretinal schisis cysts in
    ESCS and rod-cone dystrophy.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: interferon gamma-1b
      term:
        id: NCIT:C100089
        label: Interferon Gamma-1b
  evidence:
  - reference: clinicaltrials:NCT02338973
    reference_title: "Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The medicine interferon gamma-1b may help people with these diseases."
    explanation: >
      The trial evaluates topical interferon gamma-1b for the macular
      edema/schisis of ESCS.
- name: Supportive and Low-Vision Care
  description: >
    Management is largely supportive: low-vision aids and rehabilitation,
    monitoring for maculopathy, and genetic counseling for this autosomal
    recessive disorder.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
clinical_trials:
- name: NCT02338973
  phase: PHASE_I
  status: UNKNOWN
  description: >
    Pilot Phase I/II study of topically administered interferon gamma-1b for
    macular edema and intraretinal schisis cysts in rod-cone dystrophy and
    enhanced S-cone syndrome, requiring biallelic NR2E3 mutations for ESCS
    enrollment.
  target_phenotypes:
  - preferred_term: Cystoid macular edema
    term:
      id: HP:0011505
      label: Cystoid macular edema
  - preferred_term: Retinoschisis
    term:
      id: HP:0030502
      label: Retinoschisis
  evidence:
  - reference: clinicaltrials:NCT02338973
    reference_title: "Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To see if the medicine can decrease retina fluid and help prevent vision loss."
    explanation: >
      The trial's objective is to reduce intraretinal fluid and prevent vision
      loss in ESCS and rod-cone dystrophy.